Dapagliflozin as add‐on therapy in Asian patients with type 2 diabetes inadequately controlled on insulin with or without oral antihyperglycemic drugs: A randomized controlled trial
Year: 2018
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Journal of Diabetes
Institutions: China-Japan Friendship Hospital, Jiangsu Province Hospital, Nanjing First Hospital, Nanjing Medical University, Shanghai Medical College of Fudan University, Fudan University, Huashan Hospital, Sun Yat-sen University, Second Xiangya Hospital of Central South University, Samsung Medical Center, Sungkyunkwan University, AstraZeneca (United States), Bristol-Myers Squibb (United States)
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: AstraZeneca
OpenAlex ID: W2772966699
